Secondary Logo

Journal Logo

August 2016 - Volume 38 - Issue 4
pp: 423-557

Clinical Practice Recommendations for the Management and Prevention of Cisplatin-Induced Hearing Loss Using Pharmacogenetic Markers

Lee, Jong W.; Pussegoda, Kusala; Rassekh, Shahrad R.; More

Therapeutic Drug Monitoring. 38(4):423-431, August 2016.

Prospective Randomized Trial Investigating the Influence of Pharmaceutical Care on the Intra-Individual Variability of Tacrolimus Concentrations Early After Kidney Transplant

Bessa, Adrieli B.; Felipe, Claudia R.; Hannun, Pedro; More

Therapeutic Drug Monitoring. 38(4):447-455, August 2016.

Dried Blood Spot Methodology in Combination With Liquid Chromatography/Tandem Mass Spectrometry Facilitates the Monitoring of Teriflunomide

Filali-Ansary, Aziz; Lunven, Catherine; Turpault, Sandrine; More

Therapeutic Drug Monitoring. 38(4):471-482, August 2016.

The Impact of Pharmacokinetic Interactions With Eslicarbazepine Acetate Versus Oxcarbazepine and Carbamazepine in Clinical Practice

Johannessen Landmark, Cecilie; Svendsen, Torleiv; Dinarevic, Jasmin; More

Therapeutic Drug Monitoring. 38(4):499-505, August 2016.

Comparison of Population Pharmacokinetics Based on Steady-State Assumption Versus Electronically Monitored Adherence to Lopinavir, Atazanavir, Efavirenz, and Etravirine: A Retrospective Study

Fuchs, Aline; Rotzinger, Aurélie; Cavassini, Matthias; More

Therapeutic Drug Monitoring. 38(4):506-515, August 2016.